Document Detail


Darwin, medicine and cancer.
MedLine Citation:
PMID:  19940013     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
'Nothing in biology makes sense except in the light of evolution'! So said Theodore Dobzhansky. It is extraordinary how little Darwinism and post-Darwinian evolutionary science has penetrated medicine despite the fact that all biology is built upon its foundations. Randy Nesse, one of the fathers of Darwinian medicine, recently observed that doctors 'know the facts but not the origins'. Clearly, then, in this auspicious year-200 years since Charles Darwin's birth and 150 years since the first edition of the Origin of Species-it is time to reconsider Darwin's legacy to medicine and to invite evolution back into the biomedical fold. Here, we consider the legacy of Darwin and the contribution of the other great evolutionists such as Ernst Mayr to cancer and medicine.
Authors:
A D Purushotham; R Sullivan
Related Documents :
9605213 - A.j. ladman: managing editor of the anatomical record, 1968-1998.
11769323 - The effects of temperature, altitude and latitude on the arrival and departure dates of...
10164863 - Physicians as executives: boon or boondoggle?
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Review     Date:  2009-11-25
Journal Detail:
Title:  Annals of oncology : official journal of the European Society for Medical Oncology / ESMO     Volume:  21     ISSN:  1569-8041     ISO Abbreviation:  Ann. Oncol.     Publication Date:  2010 Feb 
Date Detail:
Created Date:  2010-01-29     Completed Date:  2010-05-06     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9007735     Medline TA:  Ann Oncol     Country:  England    
Other Details:
Languages:  eng     Pagination:  199-203     Citation Subset:  IM    
Affiliation:
King's College London, London, UK.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Evolution*
Genetic Fitness
Humans
Medicine / methods*,  trends
Neoplasms / etiology*,  therapy*
Research / trends
Comments/Corrections
Comment In:
Ann Oncol. 2010 Apr;21(4):908   [PMID:  20089565 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A phase I study of axitinib (AG-013736) in combination with bevacizumab plus chemotherapy or chemoth...
Next Document:  Fentanyl buccal soluble film (FBSF) for breakthrough pain in patients with cancer: a randomized, dou...